HSCS HeartSciences Inc.

AI Employees for E-CommerceBeta

Unlock 24/7 fully automated AI staff for your online store. Experience the future of e-commerce operations—no humans required. Limited closed beta access!

Get Early Access →

Subscribe to $HSCS

HeartSciences Inc.

Subscribe to $HSCS

$HSCS

Industrial Specialties

Health Care

IPO Year: 2022

Exchange: NASDAQ

Recent Analyst Ratings for HeartSciences Inc.

Date	Price Target	Rating	Analyst

See more ratings

HeartSciences Inc. Press Releases

Fastest customizable press release news feed in the world

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to enable earlier detection of heart disease, today announced the signing of its first commercial customer for the MyoVista Insights™ platform: Westcliffe Health Innovations, based in the United Kingdom. This milestone follows the recent launch of MyoVista Insights and the initiation of an early adopter program for reference sites earlier this month. Westcliffe Health Innovations provides cardiology services to the U.K. National Health Service (NHS) in the Bradfor
5/29/25 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
MIAMI, May 21, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 – Presenting Today, May 21, 2025 8:45Virtual Lobby opens.Register for the Conference. If you already registered, go ba
5/21/25 7:00:00 AM ET
$ASPI
$ATCH
$CIA
$CLNN
Major Chemicals
Industrials
Finance: Consumer Services
Finance
HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
Southlake, TX, May 20, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that Chief Executive Officer Andrew Simpson will deliver a live presentation and participate in a Q&A session at the Emerging Growth Conference 82. Event Details: Date: Wednesday, May 21, 2025 Time: 10:15 AM EDT | 7:15 AM PDT Format: Virtual presentation with live Q&A Registration To attend this live, interactive online event, please register though: Emerging Growth Conference 82 This event prov
5/20/25 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream
MIAMI, May 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 82nd Emerging Growth Conference on May 21 & 22, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1May 21, 2025 8:45Virtual Lobby opens.Register for the Conference. If you already registered, go back to the
5/20/25 7:00:00 AM ET
$ASPI
$ATCH
$CIA
$CLNN
Major Chemicals
Industrials
Finance: Consumer Services
Finance
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
Southlake, TX, May 08, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it will host a live investor webinar on Wednesday, May 14, 2025, at 2:00 p.m. EDT | 11:00 a.m. PDT, featuring a presentation and Q&A session with CEO Andrew Simpson. Register Now To attend the webinar and participate in the live Q&A, please register through: HeartSciences Investor Webinar May 14th at 2:00 pm EDT This is an opportunity for investors to gain insight into HeartSciences' missi
5/8/25 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
Southlake, TX, May 07, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Dr. Girish Nadkarni, MD, Dr. Joshua Lampert, MD, and Dr. Akhil Vaid, MBBS, to its Scientific Advisory Board. These appointments underscore HeartSciences' commitment to advancing and transforming data-driven AI-ECG technology. "We are honored to welcome Dr. Girish Nadkarni, Dr. Joshua Lampert, and Dr. Akhil Vaid to our Scientific Advisory Board," said Andrew Simpson, CEO of HeartScien
5/7/25 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced today that it has launched the MyoVista InsightsTM platform and related early adopter program for select reference sites. MyoVista Insights is a cloud-native next-generation ECG Management System designed to enhance both clinical decision-making and healthcare IT efficiency. It will integrate company developed and third-party AI-ECG algorithms as part of future releases and the current platform off
5/1/25 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
Southlake, TX, March 13, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today reported financial results for the third quarter fiscal 2025 ended January 31, 2025 and provided a business update. Third Fiscal Quarter 2025 Highlights: During the third quarter of fiscal year 2025 ("Q3 FY2025") and to date in 2025, HeartSciences has seen material progress towards FDA submissions of our products and there have been significant positive developments in the AI-ECG field. A summary of
3/13/25 4:15:00 PM ET
$HSCS
Industrial Specialties
Health Care
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications
Southlake, TX, March 10, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced today that it has engaged Integrous Communications, a premier investor relations firm, to enhance communication channels with investors and the investment community. Under the expert guidance of Integrous Communications, HeartSciences will embark on a comprehensive investor relations program, benefiting from Integrous Communications' proven track record in collaborating with leading medical compa
3/10/25 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results
Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS, HSCSW)) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today reported financial results for the second quarter fiscal 2025 ended October 31, 2024 and provided a business update. Second Fiscal Quarter 2025 Highlights: In the run up to the close of 2024 and the second quarter of fiscal year 2025 ("Q2 FY2025"), HeartSciences saw across the board material progress and more positive developments for the field of AI-ECG, its MyoVista® wavECGTM device, MyoVista® Insigh
12/16/24 4:15:00 PM ET
$HSCS
Industrial Specialties
Health Care

HeartSciences Inc. Leadership Updates

Live Leadership Updates

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
Southlake, TX, May 07, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Dr. Girish Nadkarni, MD, Dr. Joshua Lampert, MD, and Dr. Akhil Vaid, MBBS, to its Scientific Advisory Board. These appointments underscore HeartSciences' commitment to advancing and transforming data-driven AI-ECG technology. "We are honored to welcome Dr. Girish Nadkarni, Dr. Joshua Lampert, and Dr. Akhil Vaid to our Scientific Advisory Board," said Andrew Simpson, CEO of HeartScien
5/7/25 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
HeartSciences Adds Key Advisor to its Scientific Advisory Board
Southlake, TX, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Dr. Partho P. Sengupta, MD, MBBS, FACC, to its Scientific Advisory Board. "Dr. Sengupta has been an author on multiple peer reviewed AI-ECG publications using the Company's technology and we are delighted to have someone of his caliber join our growing Scientific Advisory Board," said Andrew Simpson, CEO of HeartSciences. "Dr. Sengupta has
2/26/24 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
HeartSciences Expands its Scientific Advisory Board
Southlake, TX, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Jordan B. Strom M.D., M.Sc., to its Scientific Advisory Board. "Dr. Strom has been assisting us in recent interactions with the FDA and we are delighted to welcome him to our Scientific Advisory Board as we prepare for FDA submission of our MyoVista device and cloud platform, in addition to algorithms licensed from the Icahn School of Medi
2/12/24 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
HeartSciences Appoints New Scientific Advisory Board Member
Southlake, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the appointment of Benjamin Glicksberg, Ph.D. to its Scientific Advisory Board. "We are delighted to welcome Dr. Glicksberg, an elite data scientist and an instrumental leader in the establishment of the AI-ECG program at the Icahn School of Medicine at Mount Sinai, New York (Mount Sinai) to HeartSciences' Scientific Advisory Board," said Andrew Simpson, CEO
2/1/24 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
HeartSciences Signs Distribution Agreement with FJ Medical, Denmark
Southlake, TX, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has signed a distribution agreement with FJ Medical, Denmark. FJ Medical has been appointed as HeartSciences' distributor for the MyoVista® wavECGTM and related supplies for the Nordic countries of Denmark, Sweden, Norway and Finland. FJ Medical has more than 23 years of experience selling cardiac imaging and screening equipment in the Nordic region and i
8/31/23 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care
HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results
Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today provided a business update and reported financial results for the fiscal year ended April 30, 2023. Key milestones during Fiscal 2023 and to date: Completed patient enrollment for the MyoVista® wavECGTM multi-center pivotal study; on track for FDA submission later in the year;Further expansion of the IP portfolio in the US and internationally, bringing the total number
7/19/23 9:00:00 AM ET
$HSCS
Industrial Specialties
Health Care

HeartSciences Inc.

Recent Analyst Ratings for HeartSciences Inc.

HeartSciences Inc.

Recent Analyst Ratings for HeartSciences Inc.

HeartSciences Inc. Press Releases

Fastest customizable press release news feed in the world

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream

HeartSciences' CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025

Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream

HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

HeartSciences Inc. Financials

Live finance-specific insights

HeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive Developments

HeartSciences Inc. Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Heart Test Laboratories Inc.

SEC Form SC 13G filed by Heart Test Laboratories Inc.

SEC Form SC 13D filed by Heart Test Laboratories Inc.

SEC Form SC 13D filed by Heart Test Laboratories Inc.

SEC Form SC 13G filed by Heart Test Laboratories Inc.

SEC Form SC 13G filed by Heart Test Laboratories Inc.

HeartSciences Inc. Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Director Bent Bruce

SEC Form 4 filed by Officer Hilz Mark T

SEC Form 4 filed by Director Wells David R.

SEC Form 4 filed by Officer Watson Danielle

SEC Form 4 filed by Director Szymczak Brian

SEC Form 4 filed by Officer Simpson Andrew

Officer Simpson Andrew acquired 17 shares, increasing direct ownership by 0.22% to 7,629 units (SEC Form 4)

SEC Form 4 filed by Simpson Andrew

SEC Form 4 filed by Wells David R.

SEC Form 4 filed by Szymczak Brian

HeartSciences Inc. SEC Filings

HeartSciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

HeartSciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events

SEC Form 253G2 filed by HeartSciences Inc.

HeartSciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

HeartSciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SEC Form 10-Q filed by HeartSciences Inc.

SEC Form 253G2 filed by HeartSciences Inc.

SEC Form QUALIF filed by HeartSciences Inc.

SEC Form 1-A filed by HeartSciences Inc.

HeartSciences Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits

HeartSciences Inc. Leadership Updates

Live Leadership Updates

HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board

HeartSciences Adds Key Advisor to its Scientific Advisory Board

HeartSciences Expands its Scientific Advisory Board

HeartSciences Appoints New Scientific Advisory Board Member

HeartSciences Signs Distribution Agreement with FJ Medical, Denmark

HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results